Justin C Brown1, Michael O Harhay1, Meera N Harhay2. 1. Center for Clinical Epidemiology & Biostatistics, University of Pennsylvania, USA. 2. Division of Nephrology, Department of Medicine, Drexel University College of Medicine, USA.
Abstract
OBJECTIVE: This study aimed to characterize the relationship of patient-reported functional limitations, gait speed, and mortality risk among cancer survivors. MATERIALS AND METHODS: This study included cancer survivors from the Third National Health and Nutrition Survey. Patient-reported functional limitations were quantified by asking participants to assess their ability to complete five tasks: (1) walking 1/4 mi, (2) walking up 10 steps, (3) stooping, crouching, or kneeling, (4) lifting or carrying an object of 10 lb, and (5) standing up from an armless chair. Gait speed was quantified using a 2.4-meter walk. Vital status was obtained through the United States National Center for Health Statistics. RESULTS: The study sample included 428 cancer survivors who averaged 72.1 years of age. The average number of patient-reported functional limitations was 1.8 (out of 5) and 66% of participants reported ≥1 functional limitation. Patient-reported functional limitations and gait speed were related, such that each functional limitation associated with a -0.08m/s slower gait speed (95% confidence interval: -0.10 to -0.06; P<0.001). During a median follow-up of 11years, 329 (77%) participants died. In multivariable-adjusted analysis, patient-reported functional limitations and survival were related, such that each additional reported functional limitation was associated with a 19% increase in the risk of death (95% confidence interval: 9% to 29%; P<0.001). CONCLUSION: Patient-reported functional limitations are prevalent among cancer survivors, and associate with slower gait speeds and shorter survival. These data may provide increased insight on long-term prognosis and inform clinical decision-making by identifying subgroups of cancer survivors who may benefit from rehabilitative intervention.
OBJECTIVE: This study aimed to characterize the relationship of patient-reported functional limitations, gait speed, and mortality risk among cancer survivors. MATERIALS AND METHODS: This study included cancer survivors from the Third National Health and Nutrition Survey. Patient-reported functional limitations were quantified by asking participants to assess their ability to complete five tasks: (1) walking 1/4 mi, (2) walking up 10 steps, (3) stooping, crouching, or kneeling, (4) lifting or carrying an object of 10 lb, and (5) standing up from an armless chair. Gait speed was quantified using a 2.4-meter walk. Vital status was obtained through the United States National Center for Health Statistics. RESULTS: The study sample included 428 cancer survivors who averaged 72.1 years of age. The average number of patient-reported functional limitations was 1.8 (out of 5) and 66% of participants reported ≥1 functional limitation. Patient-reported functional limitations and gait speed were related, such that each functional limitation associated with a -0.08m/s slower gait speed (95% confidence interval: -0.10 to -0.06; P<0.001). During a median follow-up of 11years, 329 (77%) participants died. In multivariable-adjusted analysis, patient-reported functional limitations and survival were related, such that each additional reported functional limitation was associated with a 19% increase in the risk of death (95% confidence interval: 9% to 29%; P<0.001). CONCLUSION:Patient-reported functional limitations are prevalent among cancer survivors, and associate with slower gait speeds and shorter survival. These data may provide increased insight on long-term prognosis and inform clinical decision-making by identifying subgroups of cancer survivors who may benefit from rehabilitative intervention.
Authors: Stephanie Studenski; Subashan Perera; Dennis Wallace; Julie M Chandler; Pamela W Duncan; Earl Rooney; Michael Fox; Jack M Guralnik Journal: J Am Geriatr Soc Date: 2003-03 Impact factor: 5.562
Authors: Christine Miaskowski; Melisa L Wong; Bruce A Cooper; Judy Mastick; Steven M Paul; Katherine Possin; Michael Steinman; Janine Cataldo; Laura B Dunn; Christine Ritchie Journal: J Pain Symptom Manage Date: 2017-07-15 Impact factor: 3.612
Authors: Maria C Swartz; Zakkoyya H Lewis; Elizabeth J Lyons; Kristofer Jennings; Addie Middleton; Rachel R Deer; Demi Arnold; Kaitlin Dresser; Kenneth J Ottenbacher; James S Goodwin Journal: Arch Phys Med Rehabil Date: 2017-04-17 Impact factor: 3.966
Authors: Ryan J Marker; Emily Cox-Martin; Catherine M Jankowski; W Thomas Purcell; John C Peters Journal: Support Care Cancer Date: 2017-12-21 Impact factor: 3.603
Authors: Inger Utne; Bruce A Cooper; Christine Ritchie; Melisa Wong; Laura B Dunn; Borghild Loyland; Ellen Karine Grov; Marilyn J Hammer; Steven M Paul; Jon D Levine; Yvette P Conley; Kord M Kober; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2020-08-03 Impact factor: 2.398
Authors: Allison Magnuson; Mina S Sedrak; Cary P Gross; William P Tew; Heidi D Klepin; Tanya M Wildes; Hyman B Muss; Efrat Dotan; Rachel A Freedman; Tracey O'Connor; William Dale; Harvey J Cohen; Vani Katheria; Anait Arsenyan; Abrahm Levi; Heeyoung Kim; Supriya Mohile; Arti Hurria; Can-Lan Sun Journal: J Clin Oncol Date: 2021-01-14 Impact factor: 44.544
Authors: Elizabeth A Salerno; Pedro F Saint-Maurice; Erik A Willis; Steven C Moore; Loretta DiPietro; Charles E Matthews Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-03-04 Impact factor: 4.090
Authors: Dongyu Zhang; Linn Abraham; Joshua Demb; Diana L Miglioretti; Shailesh Advani; Brian L Sprague; Louise M Henderson; Tracy Onega; Karen J Wernli; Louise C Walter; Karla Kerlikowske; John T Schousboe; Ellen S O'Meara; Dejana Braithwaite Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-06-02 Impact factor: 4.254